METFORMIN FXS
  • Home
  • About
    • About the Trial
    • About Fragile X
  • Inclusion/Exclusion Criteria
  • Plan Your Visit
  • Resources
    • Documents
    • Videos
    • Websites
  • Other Study Sites
    • CHU Sainte-Justine - English
    • CHU Sainte-Justine - French
    • UC Davis MIND Institute
  • FAQ
  • Contact
  • Home
  • About
    • About the Trial
    • About Fragile X
  • Inclusion/Exclusion Criteria
  • Plan Your Visit
  • Resources
    • Documents
    • Videos
    • Websites
  • Other Study Sites
    • CHU Sainte-Justine - English
    • CHU Sainte-Justine - French
    • UC Davis MIND Institute
  • FAQ
  • Contact
Search
Researchers are testing the effectiveness of Metformin to help improve daily living for individuals with Fragile X Syndrome (FXS)​


In previous studies, Metformin has been shown to improve certain symptoms and difficulties experienced by individuals with FXS, We are looking for participants in a study that will determine the safety and benefits of Metformin for these individuals.

​Who can participate?
Individuals aged 6-35 who have been diagnosed with FXS (and fit the Inclusion/Exclusion critera).

What will participants do?
Participate in a 4-month study which includes 3 clinic visits and 5 phone calls while taking Metformin orally.
Complete various tasks, questionnaires and examinations by a physician or researcher.
Participants will also have blood drawn, as well as urine and stool samples taken.
Site powered by Weebly. Managed by SiteGround
  • Home
  • About
    • About the Trial
    • About Fragile X
  • Inclusion/Exclusion Criteria
  • Plan Your Visit
  • Resources
    • Documents
    • Videos
    • Websites
  • Other Study Sites
    • CHU Sainte-Justine - English
    • CHU Sainte-Justine - French
    • UC Davis MIND Institute
  • FAQ
  • Contact